Ligo Analytics

Executive Summary

Ligo Analytics is a Texas-based startup developing a comprehensive GPU-based software platform, CryoEMMA®, for macromolecule structure determination via cryo-electron microscopy (cryoEM). Founded in 2018, the company addresses a critical bottleneck in structural biology by automating and accelerating the workflow from data collection to atomic model generation, leveraging novel numerical algorithms and AI/ML to improve speed, quality, and robustness. The cryoEM market is expanding rapidly due to its advantages in resolving complex biological structures, and Ligo's integrated solution positions it to capture value as academic and pharmaceutical labs seek to increase throughput and reproducibility. With a growing demand for structure-based drug discovery, Ligo's software could become an essential tool for researchers, potentially disrupting traditional methods. However, the startup operates in a competitive landscape with established players like Thermo Fisher and newer AI-native firms, requiring differentiation and commercial traction to scale.

Upcoming Catalysts (preview)

• Q4 2026Commercial Launch or Major Upgrade of CryoEMMA Platform70% success
• 2027Strategic Partnership with a Major Pharma or CRO50% success
• 2027Series A Funding Round Announcement60% success